Study of β-adrenoreceptor antagonistic activity of DPJ 904 in rats

Pharmacology

Volumn 74, Issue 1, 2005, Pages 1-5

  Nandakumar, K ^a   Bansal, S K ^a   Singh, Randhir ^a   Mohite, A J ^a   Bodhankar, S L ^a   Jindal, D P ^c   Coumar, Mohane S ^c   Balaraman, R ^d   Bhardwaj, S H ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Serum Institute of India Ltd   (India)

^c PANJAB UNIVERSITY   (India)

^d Department of Pharmacology   (India)

Author keywords

adrenoreceptor antagonism; Blood; Colon, isolated rat; DPJ 904; Pressure, rat; Right atria, isolated rat; Uterus, isolated rat

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DPJ 904; ISOPRENALINE; POTASSIUM CHLORIDE; PROPRANOLOL; UNCLASSIFIED DRUG; URETHAN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRADYCARDIA; CHRONOTROPISM; COLON; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; FEMALE; HEART ATRIUM; HEART RATE; HYPOTENSION; INTESTINE CONTRACTION; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TACHYCARDIA; UTERUS; UTERUS RELAXATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; ISOPROTERENOL; MALE; OXIMES; RATS; RATS, WISTAR;

EID: 17844383260     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082861     Document Type: Article

References (13)

1. 3 receptors. Trends Pharmacol Sci 1997;18:257.
2. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
3. Main BG, Tucker H: Recent advances in β adrenergic blocking agents; in Ellis GP (ed): Progress in Medicinal Chemistry, vol 22. Amsterdam, Elsevier, 1985, pp 121-164.
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial. Lancet 1999;353:9-13.
5. Hoffman BB: Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists; in Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 10. New York, McGraw-Hill, 2001, pp 215-267.
6. Jindal DP, Coumar MS, Nandakumar K, Bodhankar SL, Purohit PG, Mahadik KR, et al: Synthesis, beta adrenoreceptor blocking activity and beta receptor binding affinities of 1-substituted-3-(2-isopropyl-5-methyl-phenoxy)-propan-2-ol oxalates. Farmaco 2003;58:557-562.
7. 2 adrenoreceptor agonist associated vasorelaxant activities. J Cardiovasc Pharmacol 1999;34: 10-20.
8. Verheyen A: Cardiovascular toxicology: Toxicology, pathology and methodological aspects; in Niesink RJM, Vries JD, Hollinger MA (eds): Toxicology Principles and Applications. New York. CRC Press, 1996. pp 783-815.
9. Tripathi KD: Essentials of Medical Pharmacology, ed 3. New Delhi, Jaypee Brothers, 1998, pp 160-172.
10. Chiu CC, Lin YT, Tsai CH, Liang JC, Chiang LC, Wu JR, et al: Pharmacological effects of an aldehyde type alpha/beta adrenoreceptor-blocking agent with vasodilating properties. Gen Pharmacol 2000;34:391-400.
11. Kannan J, Giridhar R, Balaraman R: Synthesis and preliminary cardiovascular activity of phenoxypropanolamines as beta-blockers. Indian J Pharmacol 1996;28:120-122.
12. Singh BH, Collet JT, Chew YC: New perspectives in the pharmacological therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980;22/4:243-301.
13. Liang JC, Yeh JL, Chiang LC, Yang YC, Sheu SH, Lai WT, et al: Labedipinedilol-A: A vanilloid based α/β adrenoreceptor blocker with calcium entry blocking and long acting antihypertensive properties. Drug Dev Res 2000;49:94-108.